Encompass Health (EHC) Expected to Announce Earnings on Thursday

Encompass Health (NYSE:EHC) is anticipated to post its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Encompass Health to post earnings of $1.29 per share and revenue of $1.5403 billion for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Encompass Health Stock Performance

Shares of NYSE EHC opened at $94.28 on Wednesday. The stock has a market capitalization of $9.49 billion, a PE ratio of 17.82, a price-to-earnings-growth ratio of 1.51 and a beta of 0.73. Encompass Health has a 52 week low of $92.53 and a 52 week high of $127.99. The stock has a 50 day moving average price of $105.22 and a 200 day moving average price of $114.68. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14.

Analyst Ratings Changes

Several research firms recently weighed in on EHC. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Barclays raised their target price on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Finally, Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus price target of $142.86.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of EHC. EP Wealth Advisors LLC increased its stake in Encompass Health by 2.4% during the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock worth $453,000 after acquiring an additional 88 shares during the period. Ancora Advisors LLC grew its holdings in shares of Encompass Health by 0.3% during the 3rd quarter. Ancora Advisors LLC now owns 47,688 shares of the company’s stock worth $6,057,000 after purchasing an additional 160 shares in the last quarter. Public Employees Retirement System of Ohio increased its position in shares of Encompass Health by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 33,450 shares of the company’s stock worth $4,249,000 after purchasing an additional 187 shares during the period. Van ECK Associates Corp raised its stake in Encompass Health by 0.3% in the third quarter. Van ECK Associates Corp now owns 78,011 shares of the company’s stock valued at $9,909,000 after purchasing an additional 266 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its position in Encompass Health by 36,200.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after purchasing an additional 362 shares during the period. 97.25% of the stock is owned by institutional investors.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.